INBS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Intelligent Bio Solutions Inc. (INBS) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available. The company's financials show ongoing losses, and technical indicators suggest a bearish trend. While there are some positive developments in revenue growth and strategic partnerships, the overall risk outweighs the potential for immediate long-term gains.
The stock is in a bearish trend with MACD below 0 (-0.534) and negatively contracting, RSI at 8.707 indicating oversold conditions, and bearish moving averages (SMA_200 > SMA_20 > SMA_5). Key support is at 5.156, with resistance at 6.814. The stock is trading pre-market at $5, near its support level.
Gross profit margin improved to 49%, and the company formed a strategic alliance with Vlepis Pty Ltd to enter the consumer health monitoring market.
The company remains unprofitable with a Q2 GAAP EPS of -$2.82 and a net income of -$2.68 million. Gross margin dropped significantly YoY, and technical indicators suggest a bearish trend. Additionally, there is no significant hedge fund or insider activity to indicate strong institutional confidence.
In Q2 2026, revenue increased by 47.62% YoY to $896,774, but net income remained negative at -$2.68 million, albeit improving by 19.03% YoY. EPS dropped to -2.82, down 43.15% YoY, and gross margin decreased to 19.83%, down 246.78% YoY. The company is still struggling to achieve profitability.
No analyst rating or price target changes available.
